BACK
GLOBAL EXECUTIVE MOVES

July 2021
ArsenalBio Announces W. Nicholas Haining as Chief Scientific Officer
ArsenalBio announced the appointment of W. Nicholas Haining, BM, BCh, as Chief Scientific Officer. He will be responsible for the company’s multi-disciplinary research and early product development efforts, leveraging more than 20 years of leadership and experience in academic medicine and biopharma.
ArsenalBio is a privately held, programmable cell therapy company focused on the realization of solid tumor cell therapy by helping more patients fight cancer and saving lives.